Eli Lilly and Biogen Release Q4 Earnings Revealing a Pitfall in Their Alzheimer’s Disease Research
Equity Research Analyst, Laura Chico, appeared on TDAN to discuss the results of Eli Lilly and Biogen’s Q4 earnings report. She discusses how the two companies compare as they research amyloid antibodies’ effect on alzheimer’s disease. For more comments from Laura Chico, view the full appearance.
Investors Faith in the U.S. Market Grows Amidst the Coronavirus Outbreak
Despite the spread of the Coronavirus, investors faith in the U.S. market grows as corporate Q4 earnings reveal profitability. Head of Equity Trading, Sahak Manuelian, appears in MarketWatch to discuss how company earnings have influenced overall market growth. For more comments from Sahak Manuelian, view the full article.